Company History
Company strategy
Career
Open position – Finance, HR, IT Administration Assistant
Licensed partners
Board of directors
Management team
About Gerd
Patient Story - Life with GERD
Patient Story - Everyday life with GERD
Linaprazan glurate
PPIs versus P-CABs
Development strategy
Clinical development
Corporate Governance Reports
General Meetings
2024
2023
2022
The work of the board
Board committees
Management
Nomination Committee
Nomination committee instructions
Remuneration
Guidelines for remuneration
Auditing
Articles of Association
Internal control
The Share
Ownership structure
Dividend policy
Analyst coverage
Financial Reports
Annual Reports
Interim Reports
Press releases
Calendar
Presentations
Cinclus Pharma presents the Q2 report for 2024
Find information about Cinclus Pharma's presentations and associated materials here.
29 Aug 2024 13:00
Webinar
On August 29th, CEO of Cinclus Pharma Christer Ahlberg, along with CFO Maria Engström, presented the…
19 Jun 2024 10:00
Interview (in Swedish) with Cinclus Pharma's CEO Christer Ahlberg in Börslunch on the upcoming listi…
18 Jun 2024 11:00
Interview with Christer Ahlberg, CEO of Cinclus Pharma, in Trading Direkt.
13 Jun 2024 10:00
Here you can watch the presentation of Cinclus Pharma and the development of linaprazan glurate, hel…
12 Jun 2024 10:00
CEO Christer Ahlberg presented Cinclus Pharma and the development of linaprazan glurate at Aktiespar…
30 May 2024 10:00
Here you can watch the full presentation (in Swedish) of Cinclus Pharma and the development of linap…
22 May 09:45 − 23 May 09:45
Here you can watch the full presentation of CInclus Pharma and the development of linaprazan glurate…
22 May 2024 08:00
Avanzas Börsdag (Avanza's Stock Exchange Day) is a collaboration between Avanza and Financial Hearin…
Back to Investors
